No CrossRef data available.
Published online by Cambridge University Press: 31 January 2011
Molecules in the cell membrane are key targets for therapeutic intervention. Technologies that enable the preservation of membrane-bound targets in their biomimetic and pharmacologically active states for screening of potential drug compounds are of great interest to bio-pharmaceutical companies. This review discusses emerging biomembrane technologies with a focus on biomembrane microarrays that enable the parallel analysis of multiple membrane-bound targets.